f.petrov
TL2 · Konya
Contributes reviews on supplier material. Based in Konya.
Joined 13 August 2025 · last posted 3h
87 posts, newest first. Showing up to 150.
-
Injection timing and sleep disruption Replied, post #4 · Wellbeing › Sleep · 28 Jul 2026 · 0 likes Fatigue during the day and poor sleep at night are different problems with different causes and get merged in most accounts here. The claim is narrower than it sounds,…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #55 · Compounds › Repair & healing peptides · 26 Jul 2026 · 0 likes Post #54 is the version of this I will quote in future. One addition. Dose-response is unstudied in humans for essentially everything in this family, which means the…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #72 · Sourcing › Regulatory · 25 Jul 2026 · 22 likes An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence.
-
Request: a per-category review queue Replied, post #116 · Meta › Feature requests · 20 Jul 2026 · 1 like Request with the use case rather than the feature. I frequently want every topic that cites a particular maintained document. At the moment I can find the document from…
-
Coming back to: Telehealth prescribing models in the US Replied, post #19 · Regional › North America · 18 Jul 2026 · 0 likes Filing a mild objection to the consensus on Telehealth prescribing models. Mild because I might be wrong; an objection because nobody has addressed the case that does…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #80 · Start Here › Welcome · 13 Jul 2026 · 13 likes Sensible. I would want the same detail before I acted on it either.
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #6 · Start Here › How to Ask · 8 Jul 2026 · 3 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
CJC-1295 with and without DAC: what the modification does Replied, post #104 · Compounds › Secretagogues & GH axis · 6 Jul 2026 · 1 like Confirming post #103 from a second method, which matters more than confirming it from a second person. GHRH analogues versus ghrelin mimetics are often conflated but…
-
Composite endpoints and the component doing the work Replied, post #5 · Evidence › Trials · 2 Jul 2026 · 21 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Insurance and replacement policies, compared Replied, post #27 · Sourcing › Logistics · 18 Jun 2026 · 1 like Post #24 is the version of this I will quote in future. One addition. Counterpoint on insurance and replacement policies, offered without confidence: the same…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #34 · Analytics › HPLC & UHPLC · 14 Jun 2026 · 10 likes The arithmetic on Carryover is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
Cold solution and stinging: the simplest fix Replied, post #30 · Practice › Administration · 30 May 2026 · 8 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. I would…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #51 · Outcomes › Progress reports · 27 May 2026 · 0 likes Post #48 is right about the mechanism and I think understates the practical bit. Nothing here is medical advice and a progress report is a description of what happened…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #61 · Compounds › Repair & healing peptides · 27 May 2026 · 6 likes Small methodological point on Stability of BPC-157: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
How shortages have affected compounding permissions — does this still hold? Replied, post #6 · Access › Shortages · 26 May 2026 · 12 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Alcohol: what is documented and what is folklore Replied, post #22 · Practice › Interactions · 22 May 2026 · 11 likes Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #42 · Sourcing › Red flags · 7 May 2026 · 12 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #55 · Practice › Administration · 30 Apr 2026 · 0 likes Building on post #52 rather than restating it. If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #30 · Practice › Dosing & titration · 29 Apr 2026 · 17 likes Coming back to post #28, because the follow-up matters more than the original answer. Answering the Micro-titration question as asked, then the question I think is…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #84 · Practice › Reconstitution · 23 Apr 2026 · 0 likes Post #82 is right about the mechanism and I think understates the practical bit. Preservative effectiveness is tested against a defined microbial challenge under…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #67 · Practice › Reconstitution · 22 Apr 2026 · 16 likes Where I part company with post #65, and it is a narrow parting. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
-
Revisiting: Absolute versus relative contraindications Replied, post #59 · Safety › Contraindications · 5 Apr 2026 · 25 likes Picking up post #57: that is the part I would want checked first. Careful with the language on Absolute versus relative contraindications. "Not detected" and "not…
-
The headache that turns out to be dehydration — the long version Replied, post #16 · Nutrition & Training › Hydration & electrolytes · 1 Apr 2026 · 5 likes Picking up post #14: that is the part I would want checked first. Source for the headache figure, since it was asked for. It is in the discussion rather than the…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #50 · Outcomes › Body composition · 30 Mar 2026 · 0 likes Lean mass in these measurements includes water, so a change in hydration appears as a change in lean mass. A guess, clearly labelled as one.
-
A single out-of-range value on an otherwise normal panel Replied, post #28 · Clinical › Bloodwork · 28 Mar 2026 · 1 like Clear enough that I do not think I have a follow-up, which is unusual.
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #10 · Pharmacology › Formulation chemistry · 23 Mar 2026 · 11 likes Fill volume and headspace: the amount of solution in a vial and the air above it affect how much the solution is exposed to oxygen during storage. Less headspace means…
-
Amylin receptor signalling and satiety — what changed since Replied, post #46 · Pharmacology › Receptor biology · 17 Mar 2026 · 8 likes Worth separating two things that post #44 runs together. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #68 · Pharmacology › Pharmacokinetics · 12 Mar 2026 · 4 likes Washout sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #7 · marked as the solution · Pharmacology › Formulation chemistry · 6 Mar 2026 · 25 likes Adding a reference point for Lyophilisation. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
Second pass at: Identical chromatograms across two different lots Replied, post #37 · Sourcing › Red flags · 2 Mar 2026 · 30 likes On post #36 — agreed on the reasoning, with one qualification. I would keep Identical chromatograms and the decision it usually gets used for separate in this thread.…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #135 · Access › International · 28 Feb 2026 · 0 likes Two sentences on Language barriers in accessing and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #52 · Analytics › Impurities & related substances · 17 Feb 2026 · 3 likes Post #50 describes the usual case. This is about the unusual one. Relative response factors mean impurities are not detected in proportion to how much of them is…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #73 · Meta › Site feedback · 16 Feb 2026 · 11 likes The most useful thing anyone has posted about topic list in this category was a table of what had been measured and by whom. That is what I would want again.
-
Mass error in ppm: the arithmetic and the caveat Replied, post #70 · Analytics › Mass spectrometry · 14 Feb 2026 · 18 likes Taking post #69 at face value and following it one step further. Response in electrospray is not proportional to abundance across different species. Using peak…
-
Tag proliferation and whether we should prune — what changed since Replied, post #9 · Meta › Site feedback · 12 Feb 2026 · 23 likes Reporting rather than recommending, on Tag proliferation. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
Second pass at: What pooling buys you and what it destroys Replied, post #17 · Evidence › Meta-analyses · 11 Feb 2026 · 11 likes I read post #13 twice before replying, because I had assumed the opposite. I keep a log for pooling buys specifically because my memory of it turned out to be…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #98 · Compounds › Oral incretins · 10 Feb 2026 · 1 like Worth separating two things that post #94 runs together. Before the thread moves on from SOUL trial and oral semaglutide — what is the sample size behind the claim? I…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #41 · Clinical › Bloodwork · 25 Jan 2026 · 23 likes Bringing the actual numbers with intervals to an appointment is far more useful than describing them, and clinicians here consistently say so. One case, stated as one…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #39 · Documentation › Wiki requests · 15 Jan 2026 · 3 likes A document with no maintainer becomes wrong quietly, which is worse than not existing, because it carries the authority of a maintained page. It is a small point and it…
-
Managing an unplanned gap in supply Replied, post #2 · Access › Shortages · 7 Jan 2026 · 20 likes Adding the measurement that the opening post says would settle it. Supply interruptions: official shortage notices are published by regulatory agencies. That is the…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #22 · Pharmacology › Receptor biology · 22 Dec 2025 · 7 likes Post #20 put the caveat in the right place and I want to underline it. Signalling through cyclic AMP is the canonical pathway and is not the only one. Beta-arrestin…
-
[2026 update] Currency conversion and the cost you did not see Replied, post #4 · Sourcing › Payments · 18 Dec 2025 · 20 likes Two sentences on Currency conversion and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
-
Aggregates and why a purity assay may miss them entirely Replied, post #5 · Analytics › Impurities & related substances · 12 Dec 2025 · 0 likes Aggregates was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #108 · Documentation › Doc review · 8 Dec 2025 · 1 like Post #107 answers the question as asked. The question underneath it is different. Reviewing your own nomination is fine and is not sufficient. Somebody else has to read…
-
[2026 update] What steady state means for the decision to escalate Replied, post #71 · Practice › Dosing & titration · 12 Nov 2025 · 0 likes Noted, and thank you for writing it out rather than summarising it.
-
Documentation that appears only after payment Replied, post #74 · Sourcing › Red flags · 11 Nov 2025 · 30 likes Nothing here should be read as an accusation against a named company, and the guidelines exist so that reports remain reports. I would not lead a decision with this,…
-
Pooling trials with different estimands — what changed since Replied, post #47 · Evidence › Meta-analyses · 6 Nov 2025 · 1 like I had written a reply contradicting post #45 and deleted it. Here is what survived. Overlapping populations across included trials inflate the apparent sample size. It…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #88 · Practice › Reconstitution · 29 Oct 2025 · 3 likes I read post #84 twice before replying, because I had assumed the opposite. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither…
-
Publishing an inconvenient result: a case study — the long version Replied, post #12 · Sourcing › Independent verification · 17 Oct 2025 · 24 likes Where I part company with post #8, and it is a narrow parting. Where two services agree with each other and with the declared figure, that is a genuinely strong result…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #20 · Compounds › Semaglutide · 30 Sep 2025 · 25 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Reading an interaction checker output critically Replied, post #7 · Practice › Interactions · 18 Sep 2025 · 0 likes Gastrointestinal symptoms from one compound can mask or mimic an interaction with another. Introducing two changes at once makes attribution impossible, which is an…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #10 · Documentation › Doc review · 31 Aug 2025 · 28 likes Where content is lifted from a topic, attribution should be in the document rather than only in the review thread. Not disagreeing with anyone above, just adding the…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #70 · Evidence › Journal club · 20 Aug 2025 · 28 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.
-
Insomnia at a dose step: reported experiences Replied, post #3 · marked as the solution · Wellbeing › Sleep · 3 Aug 2025 · 20 likes Reflux at night follows directly from delayed gastric emptying and is a mechanical explanation for a complaint often attributed elsewhere.
-
Publishing an inconvenient result: a case study Replied, post #51 · Sourcing › Independent verification · 18 Jul 2025 · 2 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. That is where I would start, not where I would stop.
-
Follow-up: Requesting a page: what makes a good request Replied, post #46 · Documentation › Wiki requests · 9 Jun 2025 · 0 likes Objections to a request belong in the open, and a request that survives an objection is a stronger page for it.
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #12 · Evidence › Trials · 4 Jun 2025 · 9 likes Post #10 is the version of this I will quote in future. One addition. A comparator at less than its maximum licensed dose changes what a head-to-head result means. It…
-
Pregnancy as an absolute contraindication Replied, post #17 · Safety › Contraindications · 17 May 2025 · 0 likes Labelling differs between jurisdictions for the same molecule, so quoting a contraindication should say which document it comes from. Not the whole picture, but the…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #13 · Outcomes › Body composition · 7 May 2025 · 0 likes Circumference measurements at marked sites, taken consistently, track composition change better than most people expect for the cost.
-
Coverage for the indication versus for the drug Replied, post #31 · Access › Insurance & coverage · 16 Apr 2025 · 0 likes This follows post #30 rather than contradicting it. Source for the coverage figure, since it was asked for. It is in the discussion rather than the abstract, which is…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #107 · Sourcing › Vendor reports · 18 Mar 2025 · 0 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide. One case, stated as one case.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #64 · Sourcing › Regulatory · 2 Mar 2025 · 1 like Pharmaceutical compounding rules is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly.…
-
Consistent declarations and why they matter more than clever ones Replied, post #109 · Sourcing › Logistics · 1 Mar 2025 · 24 likes Confirming post #106 from a second method, which matters more than confirming it from a second person. Document outcomes rather than forecasting them. A forecast in…
-
Consistent declarations and why they matter more than clever ones Replied, post #72 · Sourcing › Logistics · 23 Feb 2025 · 23 likes Post #69 put the caveat in the right place and I want to underline it. Adding a reference point for consistent declarations. Mine is a single case, collected without…
-
Protein density versus volume when you cannot eat much Replied, post #100 · Nutrition & Training › Protein & intake · 9 Feb 2025 · 31 likes Narrowing post #99, because the general version has more than one answer. I would put moderate confidence on the mainstream reading of protein density versus volume and…
-
A promotion I argued against, and why I lost Replied, post #81 · Documentation › Doc review · 1 Feb 2025 · 0 likes Building on post #80 rather than restating it. A request rather than an answer: could whoever has the primary source for promotion post it? I have seen the claim three…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #3 · Documentation › Doc review · 26 Jan 2025 · 0 likes Adding a null result on draft on reconstitution arithmetic. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Reading a supplementary appendix and finding the interesting part Replied, post #76 · Evidence › Trials · 25 Jan 2025 · 0 likes On post #72 — agreed on the reasoning, with one qualification. Reading a supplementary appendix is a good example of a question where the honest answer is boring and…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #28 · Compounds › Secretagogues & GH axis · 12 Jan 2025 · 18 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
Follow-up: Individual participant data versus aggregate data Replied, post #64 · Evidence › Meta-analyses · 10 Jan 2025 · 32 likes Picking up post #63: that is the part I would want checked first. What I would check first on Individual participant data versus aggregate is whether the thing being…
-
Turnaround times and what they mean for a decision — one year on Replied, post #28 · Sourcing › Independent verification · 8 Jan 2025 · 0 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.…
-
What we do not know about retatrutide, listed explicitly Replied, post #48 · Compounds › Retatrutide · 8 Jan 2025 · 0 likes Post #45 is right about the mechanism and I think understates the practical bit. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #143 · Compounds › Oral incretins · 29 Dec 2024 · 2 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
Body image changing more slowly than the body Replied, post #99 · Wellbeing › Mental health · 22 Dec 2024 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
[2026 update] New subcategory: rationale and scope Replied, post #60 · Meta › Announcements · 12 Dec 2024 · 3 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope. Adding it because I spent an…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #63 · Compounds › Tirzepatide · 30 Nov 2024 · 0 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #28 · Practice › Reconstitution · 28 Nov 2024 · 28 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #34 · Access › Insurance & coverage · 20 Nov 2024 · 0 likes Practical answer on Step therapy requirements, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether…
-
EMA product information as a primary source — does this still hold? Replied, post #103 · Regional › European Union · 17 Nov 2024 · 0 likes Having read the whole EMA product information thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a…
-
EMA product information as a primary source — does this still hold? Replied, post #99 · Regional › European Union · 17 Nov 2024 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
When to suspect the method rather than the sample Replied, post #23 · Analytics › Method validation · 13 Oct 2024 · 18 likes Specificity is the first question: does the method separate the analyte from everything reasonably expected to be present? A method that has not been challenged with…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #9 · Start Here › Welcome · 11 Oct 2024 · 13 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #31 · Compounds › Other compounds · 4 Oct 2024 · 3 likes I read post #28 twice before replying, because I had assumed the opposite. Melanocortin agonists would be much easier to settle if anyone reported the denominator.…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #91 · Sourcing › Independent verification · 28 Sep 2024 · 0 likes Where I part company with post #90, and it is a narrow parting. Splitting a vial is well covered in the tag pages, and the older discussions are better than the recent…
-
The topic list is dense — is that deliberate? Replied, post #22 · Meta › Site feedback · 5 Sep 2024 · 23 likes I read post #20 twice before replying, because I had assumed the opposite. Small methodological point on topic list: repeating a measurement is cheap and resolves most…
-
What a stability-indicating method is and how you demonstrate one — one year on Started this topic · Analytics › Method validation · 7 Jul 2024 · 11 likes What a stability-indicating method is and how you demonstrate one — one year on I have a specific reason for asking rather than idle curiosity, and the context is…
-
Spreadsheets: an appreciation Replied, post #19 · Lounge › Off topic · 8 Jun 2024 · 30 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion. I…